{"actionType":"ANTAGONIST","mechanismOfAction":"Estrogen receptor alpha antagonist","chemblIds":["CHEMBL3545210","CHEMBL3545211"],"targetName":"Estrogen receptor alpha","targetType":"single protein","targets":["ENSG00000091831"],"references":[{"source":"Other","ids":["http://www.sri.com/newsroom/press-releases/sri-nobelpharma-partner-endometriosis-drug-development"],"urls":["http://www.sri.com/newsroom/press-releases/sri-nobelpharma-partner-endometriosis-drug-development"]},{"source":"PubMed","ids":["15671561"],"urls":["http://europepmc.org/abstract/MED/15671561"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Interferon alpha/beta receptor agonist","chemblIds":["CHEMBL2108677"],"targetName":"Interferon alpha/beta receptor","targetType":"protein complex","targets":["ENSG00000142166","ENSG00000159110"],"references":[{"source":"FDA","ids":["label/2014/125499lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125499lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Fibroblast growth factor receptor 1 inhibitor","chemblIds":["CHEMBL2220486"],"targetName":"Fibroblast growth factor receptor 1","targetType":"single protein","targets":["ENSG00000077782"],"references":[{"source":"PubMed","ids":["21212416","22304225","21212416","22304225","21212416","22304225"],"urls":["http://europepmc.org/abstract/MED/21212416","http://europepmc.org/abstract/MED/22304225","http://europepmc.org/abstract/MED/21212416","http://europepmc.org/abstract/MED/22304225","http://europepmc.org/abstract/MED/21212416","http://europepmc.org/abstract/MED/22304225"]},{"source":"Other","ids":["http://bit.ly/1ZGqyT3","http://bit.ly/1ZGqyT3","http://bit.ly/1ZGqyT3"],"urls":["http://bit.ly/1ZGqyT3","http://bit.ly/1ZGqyT3","http://bit.ly/1ZGqyT3"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Disialoganglioside GD2 inhibitor","chemblIds":["CHEMBL2109426"],"references":[{"source":"PubMed","ids":["21895875"],"urls":["http://europepmc.org/abstract/MED/21895875"]}]}
{"actionType":"MODULATOR","mechanismOfAction":"Estrogen receptor alpha modulator","chemblIds":["CHEMBL786","CHEMBL83"],"targetName":"Estrogen receptor alpha","targetType":"single protein","targets":["ENSG00000091831"],"references":[{"source":"DailyMed","ids":["setid=407a372d-4448-4d53-afd4-eb0e74bbc336"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=407a372d-4448-4d53-afd4-eb0e74bbc336"]},{"source":"PubMed","ids":["18819158"],"urls":["http://europepmc.org/abstract/MED/18819158"]},{"source":"Wikipedia","ids":["Tamoxifen"],"urls":["http://en.wikipedia.org/wiki/Tamoxifen"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"MAP kinase p38 alpha inhibitor","chemblIds":["CHEMBL3545201"],"targetName":"MAP kinase p38 alpha","targetType":"single protein","targets":["ENSG00000112062"],"references":[{"source":"Other","ids":["http://www.mt-pharma.co.jp/e/develop/pipeline/e_pipeline1003.pdf"],"urls":["http://www.mt-pharma.co.jp/e/develop/pipeline/e_pipeline1003.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA inhibitor","chemblIds":["CHEMBL847"],"references":[{"source":"Wikipedia","ids":["Oxamniquine"],"urls":["http://en.wikipedia.org/wiki/Oxamniquine"]},{"source":"PubMed","ids":["2617584"],"urls":["http://europepmc.org/abstract/MED/2617584"]}]}
{"actionType":"CROSS-LINKING AGENT","mechanismOfAction":"C-C chemokine receptor type 4 cross-linking agent","chemblIds":["CHEMBL1743041"],"targetName":"C-C chemokine receptor type 4","targetType":"single protein","targets":["ENSG00000183813"],"references":[{"source":"PubMed","ids":["21154168","27418646","28400633"],"urls":["http://europepmc.org/abstract/MED/21154168","http://europepmc.org/abstract/MED/27418646","http://europepmc.org/abstract/MED/28400633"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Monoamine oxidase inhibitor","chemblIds":["CHEMBL1909286"],"targetName":"Monoamine oxidase","targetType":"protein family","targets":["ENSG00000189221","ENSG00000069535"],"references":[{"source":"PubMed","ids":["13928824","13956423","14254271","4401309"],"urls":["http://europepmc.org/abstract/MED/13928824","http://europepmc.org/abstract/MED/13956423","http://europepmc.org/abstract/MED/14254271","http://europepmc.org/abstract/MED/4401309"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA inhibitor","chemblIds":["CHEMBL1201129"],"references":[{"source":"Wikipedia","ids":["DNA_methylation","DNA_methylation","DNA_methylation"],"urls":["http://en.wikipedia.org/wiki/DNA_methylation","http://en.wikipedia.org/wiki/DNA_methylation","http://en.wikipedia.org/wiki/DNA_methylation"]},{"source":"DailyMed","ids":["setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13","setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13","setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Carbonic anhydrase inhibitor","chemblIds":["CHEMBL328560"],"targetName":"Carbonic anhydrase","targetType":"protein family","targets":["ENSG00000104267","ENSG00000168748","ENSG00000133742","ENSG00000164879","ENSG00000131686","ENSG00000074410","ENSG00000118298","ENSG00000107159","ENSG00000167434","ENSG00000185015","ENSG00000169239","ENSG00000174990"],"references":[{"source":"PubMed","ids":["22468747"],"urls":["https://pubmed.ncbi.nlm.nih.gov/22468747/"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Hepatocyte growth factor receptor inhibitor","chemblIds":["CHEMBL3545050"],"targetName":"Hepatocyte growth factor receptor","targetType":"single protein","targets":["ENSG00000105976"],"references":[{"source":"DOI","ids":["10.1016/S1359-6349(10)71801-2","10.1016/S1359-6349(10)71801-2"],"urls":["http://www.sciencedirect.com/science/article/pii/S1359634910718012","http://www.sciencedirect.com/science/article/pii/S1359634910718012"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase ABL inhibitor","chemblIds":["CHEMBL1738757"],"targetName":"Tyrosine-protein kinase ABL","targetType":"single protein","targets":["ENSG00000097007"],"references":[{"source":"PubMed","ids":["21481795"],"urls":["http://europepmc.org/abstract/MED/21481795"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase B-raf inhibitor","chemblIds":["CHEMBL558752"],"targetName":"Serine/threonine-protein kinase B-raf","targetType":"single protein","targets":["ENSG00000157764"],"references":[{"source":"PubMed","ids":["23617957","26396681","23617957","26396681"],"urls":["http://europepmc.org/abstract/MED/23617957","http://europepmc.org/abstract/MED/26396681","http://europepmc.org/abstract/MED/23617957","http://europepmc.org/abstract/MED/26396681"]}]}
{"actionType":"PARTIAL AGONIST","mechanismOfAction":"Dopamine D2 receptor partial agonist","chemblIds":["CHEMBL2104864","CHEMBL2110659"],"targetName":"Dopamine D2 receptor","targetType":"single protein","targets":["ENSG00000149295"],"references":[{"source":"PubMed","ids":["17056032"],"urls":["http://europepmc.org/abstract/MED/17056032"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Opioid receptors; mu/kappa/delta agonist","chemblIds":["CHEMBL1200794","CHEMBL963"],"targetName":"Opioid receptors; mu/kappa/delta","targetType":"protein family","targets":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"references":[{"source":"DailyMed","ids":["setid=55639e61-8757-11de-8a39-0800200c9a66#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55639e61-8757-11de-8a39-0800200c9a66#nlm34090-1"]},{"source":"PubMed","ids":["17525040"],"urls":["http://europepmc.org/abstract/MED/17525040"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Heat shock protein HSP90 inhibitor","chemblIds":["CHEMBL109480"],"targetName":"Heat shock protein HSP90","targetType":"protein family","targets":["ENSG00000080824","ENSG00000096384"],"references":[{"source":"PubMed","ids":["12881371"],"urls":["http://europepmc.org/abstract/MED/12881371"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"TNF-alpha inhibitor","chemblIds":["CHEMBL1201833"],"targetName":"TNF-alpha","targetType":"single protein","targets":["ENSG00000232810"],"references":[{"source":"DailyMed","ids":["setid=f86cb4a7-c358-4136-ae57-b32bda9bba00"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f86cb4a7-c358-4136-ae57-b32bda9bba00"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Norepinephrine transporter inhibitor","chemblIds":["CHEMBL1693","CHEMBL1194666"],"targetName":"Norepinephrine transporter","targetType":"single protein","targets":["ENSG00000103546"],"references":[{"source":"PubMed","ids":["16767304","21197148","16767304","21197148"],"urls":["http://europepmc.org/abstract/MED/16767304","http://europepmc.org/abstract/MED/21197148","http://europepmc.org/abstract/MED/16767304","http://europepmc.org/abstract/MED/21197148"]},{"source":"DailyMed","ids":["setid=ba26f274-f385-49be-aef1-7041d146b9f7#nlm34090-1","setid=ba26f274-f385-49be-aef1-7041d146b9f7#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba26f274-f385-49be-aef1-7041d146b9f7#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba26f274-f385-49be-aef1-7041d146b9f7#nlm34090-1"]},{"source":"ISBN","ids":["0443-059748 PP. 406","0443-059748 PP. 406"],"urls":["http://www.isbnsearch.org/isbn/0443059748","http://www.isbnsearch.org/isbn/0443059748"]}]}
{"actionType":"OTHER","mechanismOfAction":"Disialoganglioside GD2 other","chemblIds":["CHEMBL2109417"],"references":[{"source":"PubMed","ids":["19548853"],"urls":["http://europepmc.org/abstract/MED/19548853"]}]}
{"actionType":"MODULATOR","mechanismOfAction":"Sphingosine 1-phosphate receptor Edg-1 modulator","chemblIds":["CHEMBL4297505"],"targetName":"Sphingosine 1-phosphate receptor Edg-1","targetType":"single protein","targets":["ENSG00000170989"],"references":[{"source":"Other","ids":["https://www.idorsia.com/about-idorsia/idorsia-today/our-pipeline"],"urls":["https://www.idorsia.com/about-idorsia/idorsia-today/our-pipeline"]},{"source":"PubMed","ids":["29226621","31798918"],"urls":["http://europepmc.org/abstract/MED/29226621","http://europepmc.org/abstract/MED/31798918"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Muscarinic acetylcholine receptor M3 antagonist","chemblIds":["CHEMBL3545181","CHEMBL1900528"],"targetName":"Muscarinic acetylcholine receptor M3","targetType":"single protein","targets":["ENSG00000133019"],"references":[{"source":"DailyMed","ids":["setid=1cf82d42-5ad0-4b86-838e-9230c61cf3d4#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cf82d42-5ad0-4b86-838e-9230c61cf3d4#nlm34090-1"]}]}
{"actionType":"BLOCKER","mechanismOfAction":"Sodium channel alpha subunit blocker","chemblIds":["CHEMBL1769","CHEMBL1195"],"targetName":"Sodium channel alpha subunit","targetType":"protein family","targets":["ENSG00000144285","ENSG00000183873","ENSG00000007314","ENSG00000136546","ENSG00000136531","ENSG00000169432","ENSG00000153253","ENSG00000168356","ENSG00000196876","ENSG00000185313"],"references":[{"source":"PubMed","ids":["18407836","23142844"],"urls":["http://europepmc.org/abstract/MED/18407836","http://europepmc.org/abstract/MED/23142844"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Dopamine transporter inhibitor","chemblIds":["CHEMBL2062163","CHEMBL1615439"],"targetName":"Dopamine transporter","targetType":"single protein","targets":["ENSG00000142319"],"references":[{"source":"FDA","ids":["label/2012/018074s034lbl.pdf","label/2012/018074s034lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018074s034lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018074s034lbl.pdf"]},{"source":"PubMed","ids":["23211394","23211394"],"urls":["http://europepmc.org/abstract/MED/23211394","http://europepmc.org/abstract/MED/23211394"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Hepcidin inhibitor","chemblIds":["CHEMBL2109440"],"targetName":"Hepcidin","targetType":"single protein","targets":["ENSG00000105697"],"references":[{"source":"PubMed","ids":["28327200"],"urls":["http://europepmc.org/abstract/MED/28327200"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Interleukin 17A inhibitor","chemblIds":["CHEMBL4297686"],"targetName":"Interleukin 17A","targetType":"single protein","targets":["ENSG00000112115"],"references":[{"source":"Other","ids":["https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/aby-035-phase-i-study-in-healthy-subjects-and-psoriasis-patients/"],"urls":["https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/aby-035-phase-i-study-in-healthy-subjects-and-psoriasis-patients/"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serotonin transporter inhibitor","chemblIds":["CHEMBL1201728","CHEMBL1118"],"targetName":"Serotonin transporter","targetType":"single protein","targets":["ENSG00000108576"],"references":[{"source":"DailyMed","ids":["setid=d52d4043-9795-41d0-91f1-d558fe18d680#nlm34090-1","setid=d52d4043-9795-41d0-91f1-d558fe18d680#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d52d4043-9795-41d0-91f1-d558fe18d680#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d52d4043-9795-41d0-91f1-d558fe18d680#nlm34090-1"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"D2-like dopamine receptor antagonist","chemblIds":["CHEMBL1201060","CHEMBL831"],"targetName":"D2-like dopamine receptor","targetType":"protein family","targets":["ENSG00000149295","ENSG00000151577","ENSG00000069696"],"references":[{"source":"FDA","ids":["label/2012/022549s000lbl.pdf","label/2012/022549s000lbl.pdf","label/2012/022549s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022549s000lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022549s000lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022549s000lbl.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Mineralocorticoid receptor antagonist","chemblIds":["CHEMBL3545392"],"targetName":"Mineralocorticoid receptor","targetType":"single protein","targets":["ENSG00000151623"],"references":[{"source":"Other","ids":["http://www.mt-pharma.co.jp/e/develop/pipeline/e_pipeline1409.pdf"],"urls":["http://www.mt-pharma.co.jp/e/develop/pipeline/e_pipeline1409.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"B-lymphocyte antigen CD19 inhibitor","chemblIds":["CHEMBL4298134"],"targetName":"B-lymphocyte antigen CD19","targetType":"single protein","targets":["ENSG00000177455"],"references":[{"source":"PubMed","ids":["33748165","33748165"],"urls":["https://pubmed.ncbi.nlm.nih.gov/33748165/","https://pubmed.ncbi.nlm.nih.gov/33748165/"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Bile acid receptor FXR agonist","chemblIds":["CHEMBL1551"],"targetName":"Bile acid receptor FXR","targetType":"single protein","targets":["ENSG00000012504"],"references":[{"source":"PubMed","ids":["22223860","22414767","23064163"],"urls":["http://europepmc.org/abstract/MED/22223860","http://europepmc.org/abstract/MED/22414767","http://europepmc.org/abstract/MED/23064163"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"T cell surface glycoprotein CD3 binding agent","chemblIds":["CHEMBL3990038"],"targetName":"T cell surface glycoprotein CD3","targetType":"protein complex","targets":["ENSG00000198851","ENSG00000160654","ENSG00000167286"],"references":[{"source":"Other","ids":["http://ir.macrogenics.com/news-releases/news-release-details/macrogenics-presents-flotetuzumab-data-patients-refractory-acute","https://ashpublications.org/blood/article/132/Supplement%201/764/266322/Phase-1-Cohort-Expansion-of-Flotetuzumab-a-CD123","http://ir.macrogenics.com/news-releases/news-release-details/macrogenics-presents-flotetuzumab-data-patients-refractory-acute","https://ashpublications.org/blood/article/132/Supplement%201/764/266322/Phase-1-Cohort-Expansion-of-Flotetuzumab-a-CD123"],"urls":["http://ir.macrogenics.com/news-releases/news-release-details/macrogenics-presents-flotetuzumab-data-patients-refractory-acute","https://ashpublications.org/blood/article/132/Supplement%201/764/266322/Phase-1-Cohort-Expansion-of-Flotetuzumab-a-CD123","http://ir.macrogenics.com/news-releases/news-release-details/macrogenics-presents-flotetuzumab-data-patients-refractory-acute","https://ashpublications.org/blood/article/132/Supplement%201/764/266322/Phase-1-Cohort-Expansion-of-Flotetuzumab-a-CD123"]}]}
{"actionType":"NEGATIVE ALLOSTERIC MODULATOR","mechanismOfAction":"Neuronal acetylcholine receptor; alpha3/beta4 negative allosteric modulator","chemblIds":["CHEMBL1237082","CHEMBL267936"],"targetName":"Neuronal acetylcholine receptor; alpha3/beta4","targetType":"protein complex","targets":["ENSG00000117971","ENSG00000080644"],"references":[{"source":"PubMed","ids":["19874251"],"urls":["http://europepmc.org/abstract/MED/19874251"]},{"source":"DailyMed","ids":["setid=e1fc95fe-7816-47b6-b73d-b2f644f79872"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1fc95fe-7816-47b6-b73d-b2f644f79872"]},{"source":"Wikipedia","ids":["Mecamylamine","Nicotinic_acetylcholine_receptor"],"urls":["http://en.wikipedia.org/wiki/Mecamylamine","http://en.wikipedia.org/wiki/Nicotinic_acetylcholine_receptor"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Thyroid hormone receptor agonist","chemblIds":["CHEMBL559"],"targetName":"Thyroid hormone receptor","targetType":"protein complex","targets":["ENSG00000126351","ENSG00000151090"],"references":[{"source":"PubMed","ids":["20935564","9440092"],"urls":["http://europepmc.org/abstract/MED/20935564","http://europepmc.org/abstract/MED/9440092"]},{"source":"ISBN","ids":["9780702034718 PP. 412"],"urls":["http://www.isbnsearch.org/isbn/9780702034718"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase Chk1 inhibitor","chemblIds":["CHEMBL2386889"],"targetName":"Serine/threonine-protein kinase Chk1","targetType":"single protein","targets":["ENSG00000149554"],"references":[{"source":"PubMed","ids":["21321066"],"urls":["http://europepmc.org/abstract/MED/21321066"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Peroxisome proliferator-activated receptor gamma agonist","chemblIds":["CHEMBL704"],"targetName":"Peroxisome proliferator-activated receptor gamma","targetType":"single protein","targets":["ENSG00000132170"],"references":[{"source":"PubMed","ids":["15824083","18077625","18544567","2882965","6131674","6428914","12463455","12950415","14742690"],"urls":["http://europepmc.org/abstract/MED/15824083","http://europepmc.org/abstract/MED/18077625","http://europepmc.org/abstract/MED/18544567","http://europepmc.org/abstract/MED/2882965","http://europepmc.org/abstract/MED/6131674","http://europepmc.org/abstract/MED/6428914","http://europepmc.org/abstract/MED/12463455","http://europepmc.org/abstract/MED/12950415","http://europepmc.org/abstract/MED/14742690"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Macrophage colony-stimulating factor 1 inhibitor","chemblIds":["CHEMBL2109512"],"targetName":"Macrophage colony-stimulating factor 1","targetType":"single protein","targets":["ENSG00000184371"],"references":[{"source":"Other","ids":["http://cancerres.aacrjournals.org/content/69/9_Supplement/DDT02-2","https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=617378"],"urls":["http://cancerres.aacrjournals.org/content/69/9_Supplement/DDT02-2","https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=617378"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Sarcoplasmic/endoplasmic reticulum calcium ATPase inhibitor","chemblIds":["CHEMBL3989865"],"targetName":"Sarcoplasmic/endoplasmic reticulum calcium ATPase","targetType":"protein family","targets":["ENSG00000074370","ENSG00000196296","ENSG00000174437"],"references":[{"source":"PubMed","ids":["27115568","31212948"],"urls":["http://europepmc.org/abstract/MED/27115568","http://europepmc.org/abstract/MED/31212948"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Estrogen receptor alpha agonist","chemblIds":["CHEMBL135"],"targetName":"Estrogen receptor alpha","targetType":"single protein","targets":["ENSG00000091831"],"references":[{"source":"DailyMed","ids":["setid=0f943869-41a2-4f7e-943d-dd8c17996dd8#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0f943869-41a2-4f7e-943d-dd8c17996dd8#nlm34090-1"]},{"source":"Wikipedia","ids":["Estrogen_receptor"],"urls":["http://en.wikipedia.org/wiki/Estrogen_receptor"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Histamine H1 receptor antagonist","chemblIds":["CHEMBL1200497","CHEMBL648"],"targetName":"Histamine H1 receptor","targetType":"single protein","targets":["ENSG00000196639"],"references":[{"source":"Other","ids":["www.medicines.org.uk/EMC/medicine/14672/SPC/Valoid+Tablets/#PHARMACOLOGICAL_PROPS"],"urls":["www.medicines.org.uk/EMC/medicine/14672/SPC/Valoid+Tablets/#PHARMACOLOGICAL_PROPS"]},{"source":"PubMed","ids":["20394809"],"urls":["http://europepmc.org/abstract/MED/20394809"]}]}
